Accretive Health, Inc. Stock Nyse
Equities
US00438V1035
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | R1 RCM's Q1 Results to Focus on Strategic Alternatives, Change Cyberattack, RBC Says | MT |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | 2.64B | Sales 2025 * | 2.95B | Capitalization | 5.04B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 127M | EV / Sales 2024 * | 2.6 x |
Net Debt 2024 * | 1.84B | Net Debt 2025 * | 1.62B | EV / Sales 2025 * | 2.26 x |
P/E ratio 2024 * |
-172
x | P/E ratio 2025 * |
54.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.96% |
Latest transcript on Accretive Health, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22-06-21 |
Director of Finance/CFO | - | 22-06-20 | |
John Sparby
PSD | President | 48 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 19-08-11 |
David M. Dill
BRD | Director/Board Member | 55 | 21-04-17 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 13-03-31 |
1st Jan change | Capi. | |
---|---|---|
-11.66% | 87.92B | |
+12.72% | 80.7B | |
+10.85% | 29.37B | |
-11.36% | 16.95B | |
-6.85% | 14.26B | |
+0.92% | 12.2B | |
-30.35% | 12.01B | |
-3.53% | 11.46B | |
+22.01% | 11.21B |